SVB Wealth’s PDL BioPharma, Inc. PDLI Stock Holding History

SVB Wealth’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,293	Closed	-$86K	–	604
2015 Q1	$86K	Buy	+12,293	New	+$89K	﹤0.01%	541

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SVB Wealth's PDLI Position: Q2 2015 in Review

SVB Wealth sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 12,293 shares — an estimated $86K sold.

SVB Wealth first reported a position in PDLI in Q1 2015 and held it in 1 quarter. The position peaked at $86K in Q1 2015. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

SVB Wealth reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
SVB Wealth sold 12,293 PDL BioPharma, Inc. shares in Q2 2015, an estimated $86K.
SVB Wealth first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 1 quarter.
SVB Wealth's PDL BioPharma, Inc. position peaked at $86K in Q1 2015.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on SVB Wealth's 13F filing for Q2 2015, filed 13 Aug 2015.